104 related articles for article (PubMed ID: 8951993)
21. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of thromboxane synthetase inhibitor on hypertensive renal damage in Dahl salt-sensitive rats.
Gomi T; Ikeda T; Sasaki Y; Kosugi T; Shibuya Y; Sakurai J
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S371-3. PubMed ID: 9072433
[TBL] [Abstract][Full Text] [Related]
23. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat.
Tajiri Y; Umeda F; Inoguchi T; Nawata H
J Diabetes Complications; 1994; 8(2):126-32. PubMed ID: 8061349
[TBL] [Abstract][Full Text] [Related]
24. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
25. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
26. Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine.
Chander V; Chopra K
Ren Fail; 2005; 27(4):441-50. PubMed ID: 16060134
[TBL] [Abstract][Full Text] [Related]
27. Time-dependent cyclosporine A-induced nephrotoxicity in rats.
Yamauchi H; Kobayashi E; Sugimoto K; Tsuruoka S; Yabana M; Ishii M; Fujimura A
Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):435-40. PubMed ID: 9673819
[TBL] [Abstract][Full Text] [Related]
28. Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
Kawaguchi A; Sugimoto K; Fujimura A
Life Sci; 2001 Jan; 68(10):1181-90. PubMed ID: 11228102
[TBL] [Abstract][Full Text] [Related]
29. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
30. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.
Anjaneyulu M; Tirkey N; Chopra K
Ren Fail; 2003 Sep; 25(5):691-707. PubMed ID: 14575278
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
[TBL] [Abstract][Full Text] [Related]
33. Prostanoids and cyclosporin-mediated nephrotoxicity in rats: a critical appraisal.
Casas A; Hotter G; Roselló-Catafau J; Fernández-Cruz L; Gelpí E
Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):49-53. PubMed ID: 7708820
[TBL] [Abstract][Full Text] [Related]
34. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
[TBL] [Abstract][Full Text] [Related]
35. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
36. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
37. Effect of bicarbonate administration on cyclosporine-induced nephrotoxicity in rats.
Zahmatkesh M; Kadkhodaee M; Seifi B; Shams S
Transplant Proc; 2009 Sep; 41(7):2905-6. PubMed ID: 19765469
[TBL] [Abstract][Full Text] [Related]
38. The role of eicosanoids in cyclosporine nephrotoxicity in the rat.
Erman A; Chen-Gal B; Rosenfeld J
Biochem Pharmacol; 1989 Jul; 38(13):2153-7. PubMed ID: 2735953
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
Niwa T; Maeda K; Shibata M; Yamada K
Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
[TBL] [Abstract][Full Text] [Related]
40. Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.
Rogers TS; Elzinga L; Bennett WM; Kelley VE
Transplantation; 1988 Jan; 45(1):153-6. PubMed ID: 3422115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
